Can DMARD Doses Be Safely Reduced for RA Patients? Korean Trial Says Yes.

(MedPage Today) -- Close to 90% of patients with rheumatoid arthritis (RA) well controlled on targeted therapies were able to take 50% dosage reductions without experiencing worsened disease activity in a randomized trial, South Korean researchers...